Home Research Protocols 2004009

2004009

Randomized, double blind placebo-controlled studies to evaluate the safety and tolerability of a novel Llama-derived anti-rotavirus VHH fragment in human volunteers (Part-I), and its therapeutic efficacy in children with rotavirus diarrhoea (Part-II).
Short Title Safety & efficacy trial of llama antibody fragment
Protocol No 2004009
Status Completed
Keywords LLAMA ANTIBODY, ROTAVIRUS DIARRHOEA, CHILDREN
Center Clinical Sciences
MDG(s) this protocol relates to
HPNSDP(s) this protocol relates to
PI Name Md. Shafiqul Alam Sarker
Collaborating Institutes (216) Unilever Nederland Holdings .BV., Netherlands
Funding
Summary
‹ Search All Protocols Here

Highlights